Literature DB >> 6327736

Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors.

A Ciechanover, A L Schwartz, H F Lodish.   

Abstract

With few exceptions, receptor-mediated endocytosis of specific ligands is mediated through clustering of receptor-ligand complexes in coated pits on the cell surface, followed by internalization of the complex into endocytic vesicles. During this process, ligand-receptor dissociation occurs, most probably in a low pH prelysosomal compartment. In most cases the ligand is ultimately directed to the lysosomes, wherein it is degraded, while the receptor recycles to the cell surface. We have studied the kinetics of internalization and recycling of both the asialoglycoprotein receptor and the transferrin receptor in a human hepatoma cell line. By employing both biochemical and morphological/immunocytochemical approaches, we have gained some insight into the complex mechanisms which govern receptor recycling as well as ligand sorting and targeting. We can, in particular, explain why transferrin is exocytosed intact from the cells, while asialoglycoproteins are degraded in lysosomes. We have also localized the intracellular site at which endocytosed receptor and ligand dissociate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6327736     DOI: 10.1002/jcb.240230111

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  32 in total

1.  Identification and characterization of the chicken transferrin receptor.

Authors:  J A Schmidt; J Marshall; M J Hayman
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

2.  Cell-surface insulin receptor cycling and its implication in the glycogenic response in cultured foetal hepatocytes.

Authors:  P Soubigou; E Pringault; C Plas
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection.

Authors:  Anja Habermann; Jacomine Krijnse-Locker; Heike Oberwinkler; Manon Eckhardt; Stefanie Homann; Amy Andrew; Klaus Strebel; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 4.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

5.  Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.

Authors:  Irene S Ludwig; Annemarie N Lekkerkerker; Erik Depla; Fons Bosman; René J P Musters; Stany Depraetere; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Identification of the parasite transferrin receptor of Plasmodium falciparum-infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol.

Authors:  K Haldar; C L Henderson; G A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayers.

Authors:  Erik Brewer; Anthony M Lowman
Journal:  J Biomater Sci Polym Ed       Date:  2013-12-24       Impact factor: 3.517

Review 8.  Cell surface recycling in yeast: mechanisms and machineries.

Authors:  Chris MacDonald; Robert C Piper
Journal:  Biochem Soc Trans       Date:  2016-04-15       Impact factor: 5.407

Review 9.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

10.  The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.

Authors:  Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.